After finishing at $9.34 in the prior trading day, Inogen Inc (NASDAQ: INGN) closed at $6.29, down -32.66%. In other words, the price has decreased by -$3.05 from its previous closing price. On the day, 2831481 shares were traded. INGN stock price reached its highest trading level at $7.24 during the session, while it also had its lowest trading level at $5.82.
Ratios:
Our goal is to gain a better understanding of INGN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.55 and its Current Ratio is at 2.86. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
On August 08, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $15 to $8.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INGN now has a Market Capitalization of 217.46M and an Enterprise Value of 102.19M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.46 while its Price-to-Book (P/B) ratio in mrq is 0.64. Its current Enterprise Value per Revenue stands at 0.31 whereas that against EBITDA is -2.93.
Stock Price History:
Over the past 52 weeks, INGN has reached a high of $16.49, while it has fallen to a 52-week low of $4.13. The 50-Day Moving Average of the stock is 6.79, while the 200-Day Moving Average is calculated to be 7.19.
Shares Statistics:
The stock has traded on average 572.34K shares per day over the past 3-months and 640.07k shares per day over the last 10 days, according to various share statistics. A total of 22.94M shares are outstanding, with a floating share count of 22.74M. Insiders hold about 2.46% of the company’s shares, while institutions hold 90.68% stake in the company. Shares short for INGN as of Feb 15, 2024 were 1.97M with a Short Ratio of 3.44, compared to 1.54M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.45% and a Short% of Float of 11.92%.
Earnings Estimates
Its stock is currently analyzed by 3 different market analysts. On average, analysts expect EPS of -$0.62 for the current quarter, with a high estimate of -$0.56 and a low estimate of -$0.66, while EPS last year was -$0.88. The consensus estimate for the next quarter is -$0.59, with high estimates of -$0.52 and low estimates of -$0.63.
Analysts are recommending an EPS of between -$1.9 and -$2.63 for the fiscal current year, implying an average EPS of -$2.27. EPS for the following year is -$2.13, with 4 analysts recommending between -$1.8 and -$2.69.
Revenue Estimates
1 analysts predict $80.63M in revenue for the current quarter. It ranges from a high estimate of $80.63M to a low estimate of $80.63M. As of the current estimate, Inogen Inc’s year-ago sales were $72.16M, an estimated increase of 11.70% from the year-ago figure. For the next quarter, 1 analysts are estimating revenue of $87.68M, an increase of 4.80% less than the figure of $11.70% in the same quarter last year. There is a high estimate of $87.68M for the next quarter, whereas the lowest estimate is $87.68M.
A total of 4 analysts have provided revenue estimates for INGN’s current fiscal year. The highest revenue estimate was $337M, while the lowest revenue estimate was $330.1M, resulting in an average revenue estimate of $333.85M. In the same quarter a year ago, actual revenue was $315.66M, up 5.80% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $353.06M in the next fiscal year. The high estimate is $363M and the low estimate is $345.1M. The average revenue growth estimate for next year is up 5.80% from the average revenue estimate for this year.
